Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.70
Share price
-0.57%
Change (1 day)
12.18%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ2.68 Billion

According to Galapagos NV's latest financial reports the company has ยฃ2.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ2.58 B-19.14%
2023-12-31ยฃ3.19 B-11.93%
2022-12-31ยฃ3.63 B-8.01%
2021-12-31ยฃ3.94 B-15.28%
2020-12-31ยฃ4.65 B-5.69%
2019-12-31ยฃ4.93 B324.52%
2018-12-31ยฃ1.16 B13.82%
2017-12-31ยฃ1.02 B23.19%
2016-12-31ยฃ0.82 B230.41%
2015-12-31ยฃ0.25 B71.24%
2014-12-31ยฃ0.14 B26.76%
2013-12-31ยฃ0.11 B49.35%
2012-12-31ยฃ77.45 M184.77%
2011-12-31ยฃ27.2 M-21.85%
2010-12-31ยฃ34.8 M-17.04%
2009-12-31ยฃ41.95 M61.03%
2008-12-31ยฃ26.05 M-28.08%
2007-12-31ยฃ36.23 M4.39%
2006-12-31ยฃ34.7 M113.92%
2005-12-31ยฃ16.22 M123.48%
2004-12-31ยฃ7.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
ยฃ6.13 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ13.92 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.83 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ4.25 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ55.79 M-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.80 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ3.33 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ13.66 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA